All Blogs

Dec 04, 2017

Toll-Like Receptor Modulators: Emerging therapy for many indications


Nov 29, 2017

Ketamine to work in mice


Nov 28, 2017

Biohaven’s trial ; GSK integrates; FDA Approval; Phase III trial


Nov 28, 2017

Celiac Disease (CD) – Upcoming therapies to break the stagnancy


Nov 24, 2017

Targeting cancer through CD40 agonists -A promising future


Nov 21, 2017

EMA to relocate to Amsterdam; Roche’s prospects; Amgen’s Humira Biosimilar delayed; Purdue’s opioid lawsuit


Nov 15, 2017

Chemists may help solve the air-pollution health crisis


Nov 14, 2017

Novartis ventures; Bill Gates invests; Arcus Biosciences gains; Denali and Odonate seek funding; Fosun Pharma acquires


Nov 13, 2017

Bubble Boy Syndrome (ADA-SCID) – A Rare Immunodeficiency Disorder


Nov 10, 2017

Business Cocktail